Bioform Medical (BFRM)
Recs
Large Move with Relatively Low Short Interest
Recs
BFRM offers a facial injectable product to keep aging baby boomer women's wrinkles at bay. The stock was hammered in the economic downturn due to the perception that ladies would cut back discretionary spending...and this was true. It really didn't hurt the top line too badly and as we come out of the recession this stock should really do well.
Recs
Nowhere to go but up
Recs
I have seen a pattern that if a stock has five star CAPS rating AND is near the lower end of the 52 week range, then the stock ALWAYS appreciates by 25 % over the next three months.
I would appreciate if other fools have also noticed this and would correct me if I am wrong
Recs
wrinkle filler
Recs
Bioform markets a dermal filler, Radiesse, which has potential to take market share from Restylane by Medicis. New techniques have been developed which make the injections less painful and easier to perform. The company has priced the product well to compete with other fillers and will be supplying new, thinner (read: less painful) needles with the product in the near future, pending FDA approval.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 6 of 6